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Abstract 
Background: T‑cell receptor (TCR) repertoire development is an integral part of the adaptive immune response. 
T‑cell activation requires recognition of appropriately processed antigens by the TCR. Development of a diverse 
repertoire of TCRs is therefore essential to ensure adequate protection from potential threats. The majority of T‑cells 
in peripheral blood have TCRs composed of an alpha and a beta chain. At the DNA level, the TCR genes are formed 
through directed recombination from germline sequences—the so‑called VDJ recombination [variable (V) joining 
(J) diversity (D) gene segments] which results in variations in the repertoire. The most variable part of TCRs is the Vβ 
region (VβTCR), which has multiple V segment families that can be quantitatively measured. However, only sparse 
data exists on the normal levels of the VβTCR repertoire in healthy children. We aimed to establish normal values for 
the VβTCR repertoire in atopic children without immunodeficiency.
Methods: Fifty‑three children were recruited from food allergy, drug allergy, chronic urticaria and anaphylaxis regis‑
tries and were divided into groups based on age: >0–2 years, 3–6 years, and 6–18 years. We used commercially avail‑
able and fluorescently labeled antibodies against 21 human class‑specific V segments of the TCRβ chain (Vβ) to study 
in peripheral blood the quantitative pattern of Vβ variation by flow cytometry.
Results: Children of all ages exhibited a similar pattern of TCR Vβ expression. Vβ 2 was the most commonly expressed 
family in all three age groups [9.5 % (95 % CI, 8.9, 10 %), 8.8 % (95 % CI, 7.4, 10.2 %) and 7.6 % (7.0, 8.3 %) respectively]. 
However, the percentage of Vβ 2 decreased in older children and the percentage of Vβ 1 was higher in males. TCR Vβ 
expression in our sample of atopic children did not differ substantially from previously published levels in non‑atopic 
cohorts.
Conclusion: TCR Vβ diversity follows a predictable and comparable pattern in atopic and healthy non‑atopic chil‑
dren. Establishing normal levels for healthy children with and without atopy will contribute to a better definition of Vβ 
receptor deviation in children with primary immunodeficiency and/or immunodysregulation conditions.
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Background
T-cells play the major effector role in adaptive immune 
defence [1]. The ability of T-cells to recognise a large vari-
ety of antigens is well understood. Since the discovery 
of the genetic background of the T-cell receptor (TCR), 
it is now well known that the diversity and specificity of 
T-cells are a result of gene segment recombination.
There are four distinct T-cell antigen receptor poly-
peptides (α, β, γ, and δ), which form two different heter-
odimeric chains (α:β and γ:δ). This results in two subsets 
of T-cells (T-cell αβ and T-cell γδ) [2]. The majority of 
T-cells express α:β, while a small percentage express γ:δ 
[3]. The basic structure of the TCR consists of variable 
and constant regions, with each region composed of one 
α and one β chain. The most variable part of the TCR is 
the variable region of the β chain (Vβ).
The generation of T-cell diversity occurs during the 
assembly of the TCR in the thymus through the genetic 
recombination of the V, D, and J segments [variable (V) 
joining (J) diversity (D) gene segments] [4]. The β chain is 
generated by the VDJ recombination, whereas the alpha 
chain is generated by the VJ recombination. This process 
is believed to occur through a random recombination of 
gene segments, and it produces a diverse repertoire of 
Vβ (VβTCR). In later steps, before the full maturation of 
T-cells and before the cells leave the thymus; the TCR has 
to appropriately bind a self MHC antigen (positive selec-
tion) [5]. The T-cells with TCRs that inappropriately bind 
self MHC antigens die by apoptosis.
The assessment of the Vβ repertoire of TCRs has classi-
cally been performed using two different methodologies. 
Complementarity determining regions (CDRs) length 
spectratyping is a genetic assay that uses the polymerase 
chain reaction (PCR). This method provides qualitative 
information about TCR Vβ clonality. Another method 
involves flow cytometry analyses of TCR Vβ families 
labeled with specific monoclonal antibodies. This method 
provides a quantitative assessment of TCR Vβ clones and 
is well established in clinical settings. The latter method 
provides a faster generation of results and is relatively 
easier and less expensive than the former. In addition, it 
has a high degree of reproducibility. The development of 
a large panel of monoclonal antibodies to TCRs, mainly 
against Vβ epitopes, has permitted the study of the TCR 
repertoire. By using commercial fluorescently labeled 
antibodies that cover over 75 % of the whole TCR Vβ rep-
ertoire, it is possible to quantify the cells that express a 
different Vβ repertoire. These allow for early diagnosis 
and follow up as well as response to medical manage-
ment of primary immunodeficiency diseases, immunod-
ysregulation disorders, and malignancies [6–8].
There is a limited amount of data on the normal levels 
of the VβTCR repertoire in healthy subjects, and only 
a few studies on healthy children exist [9–11]. Further, 
although there is an association between certain immu-
nodeficiencies and atopy, there are currently no studies 
assessing the potential effect of atopy on the VβTCR 
repertoire [12]. We aimed to determine the VβTCR 
repertoire in atopic children without immunodeficien-
cies, to compare the results to non-atopic children 
and to assess the effects of age, sex and different atopic 
co-morbidities.
Methods
The study was conducted between January 2014 and Feb-
ruary 2015 in Montreal, Canada. Subjects were recruited 
from the allergy and immunology clinic of the Montreal 
Children’s Hospital. The study population included 53 
healthy atopic Caucasian children under the age of 18. 
We excluded subjects with active or recent infections, 
those taking immunosuppressive medications, and those 
with any known chronic medical conditions other than 
atopy. The subjects were divided into groups based on 
age: >0–2 years, 3–6 years, and 7–18 years. Whole blood 
samples were taken from the children during their clini-
cal evaluation.
Vβ TCR analysis was performed using commercially 
available fluorescently labelled antibodies against the fol-
lowing 21 human class-specific V segments of the TCRβ 
chain: Vβ 1, Vβ 2, Vβ 3, Vβ 4, Vβ 5.2, Vβ 5.3, Vβ 7.1, Vβ 
7.2, Vβ 8, Vβ 9, Vβ 11, Vβ 12, Vβ 13.1, Vβ 13.2, Vβ 13.6, 
Vβ 14, Vβ 16, Vβ 17, Vβ 21.3, Vβ 22 and Vβ 23.
Vβ staining was determined using modified three-color 
flow cytometry with the IOTest Beta Mark TCR Reper-
toire Kit (Beckman Coulter, Marseille, France), which 
consists of monoclonal antibodies (mAbs) designed to 
identify 21 distinct TCR Vβ families. Each set consisted 
of three distinct anti-Vβ family-specific mAb labelled 
with fluorescein isothiocyanate (FITC), phycoerythrin 
(PE) or doubly labelled with FITC and PE. Fresh whole 
blood was stained simultaneously with phycoerythrin-
cyanine5 conjugated anti-CD3 (clone UCHT1). Hundred 
microlitre of whole blood was washed prior to incuba-
tion with phycoerythrin-cyanine5 conjugated anti-CD3 
antibody with 20  μl of appropriate TCR-Vβ antibody 
for 30  min in the dark at room temperature. Erythro-
cytes were lysed using fluorescence activated cell sorter 
(FACS) lysing solution (Becton–Dickinson, Oxford, UK) 
and cells were then washed. At least 30,000 CD3+ lym-
phocyte events were collected for analysis. The CD3+, 
lymphocytes were gated using forward- and side-scatter 
characteristics and cell populations gated according to 
CD3 expression.
Data acquisition was performed using a FACS Calibur 
flow cytometer and Cellquest software (BD Biosciences) 
(Fig. 1).
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The results of the data were expressed as mean ± 95 % 
confidence interval (CI). Uni- and multivariate lin-
ear regressions were used to control for potential con-
founders and assess the effects of age, sex, and atopy on 
VβTCR. All statistical analyses were conducted using R 
version 2.12.0 (2010-10-15). This study received ethics 
approval from the McGill Research Ethics Board.
Results
Among the 53 children assessed, 53  % were males. 
The majority had food allergies and chronic urticaria 
(Table 1).
Our results reveal that Vβ 2 composed the majority 
of VβTCRs in our sample (Fig. 2). The next most highly 
expressed members of the Vβ repertoire were Vβ 8 and 
Vβ 17. An important observation in this study was that 
the pattern of VβTCRs for atopic children in different 
pediatric age groups followed a pattern similar to val-
ues previously reported in non-atopic children (Table 2) 
[10].
Comparing uni and multivariate logistic regres-
sions revealed that age and sex affected the levels of Vβ 
2 and Vβ 1 respectively. The levels of Vβ 2 decreased 
in older children [beta adjusted for sex and atopic con-
dition  =  −0.1, (95  % CI, −0.2 −0.03)] and males had 
higher levels of Vβ 1 [beta adjusted for age and atopic 
condition =  0.7, 95 % CI (0.1 1.3)]. Given the effects of 
age and sex, we assessed VβTCRs for three age groups: 
0–2 years old, 3–6 years old, and 7–18 years old for males 
and females (Figs. 2, 3 and 4 and Tables 3, 4 and 5). We 
did not find significant associations between the type of 
atopic condition and the level of a specific Vβ chain.
Discussion
We report here the VβTCR repertoire in the largest sam-
ple to date of children with no immunodeficiency. Fur-
ther, our study is the first to assess the VβTCR repertoire 
in children with atopy. Our results reveal a similar dis-
tribution of VβTCRs in atopic versus previously reported 
non-atopic children. In addition, we have found that age 
and sex may affect the VβTCR repertoire.
Fig. 1 Box plots for VβTCR percentages of all CD3 cells in 53 children with atopy
Table 1 Demosgraphic and atopic characteristics
Variable % (95 % CI)
Age (years, median, IQR: interquartile range) 6 (2, 13)
Males (%) 52.8 (38.8, 66.5)
Atopic condition
 Food allergy 49.1 (35.2, 63.0)
 Chronic urticaria 35.8 (23.5, 50.2)
 Hay fever 7.5 (2.4, 19.1)
 Asthma 1.9 (0.1, 11.4)
 Drug allergy 5.7 (1.5, 16.6)
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Fig. 2 Box plots for VβTCR percentages of all CD3 cells for children 0–2 years old














Vβ_1 3.5 3.6 3.6 3·9 3.6 4.0
Vβ_2 9.5 9.9 8.8 8·8 7.6 8.7
Vβ_3 4.9 5.7 4.1 4·9 3.5 3.7
Vβ_4 2.1 2.1 2.0 2·1 2.2 2.2
Vβ_5.2 1.7 1.3 1.7 1·7 2.2 1.6
Vβ_5.3 1.3 0.73 1.3 1·2 1.1 1.0
Vβ_7.1 2.9 2.7 2.5 2·6 2.6 2.7
Vβ_7.2 1.0 1.0 1.2 1·5 1.0 1.6
Vβ_8 5.4 4.5 5.4 5·4 5.2 5.2
Vβ_9 2.2 2.9 1.8 3·3 2.1 3.4
Vβ_11 1.3 0.9 1.1 1·0 1.3 1.0
Vβ_12 1.6 1.6 1.7 1·8 1.6 1.7
Vβ_13_1 3.7 4.5 4.3 5·0 3.6 4.5
Vβ_13_2 2.4 3.1 2.9 3·5 2.8 4.0
Vβ_13.6 1.8 1.8 1.6 1·8 1.5 1.8
Vβ_14 3.6 4.5 3.5 4·5 4.0 4.0
Vβ_16 1.0 1.2 1.0 0·9 1.0 1.1
Vβ_17 5.0 5.1 4.7 5·7 5.0 5.4
Vβ_21.3 2.5 2.5 2.3 2·5 2.3 2.5
Vβ_22 3.8 3.0 3.4 3·57 3.6 3.6
Vβ_23 1.4 0.7 1.4 1·1 1.1 1.1
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There are several studies of the Vβ repertoire aimed 
at identifying the clonal pattern of TCRs or determining 
specific Vβ region(s) in different pathological conditions 
where T-cells have a fundamental role [10] for example: 
autoimmune disorders [13, 14] HIV infection [15], malig-
nancy [16], asthma [17], and immunodeficiency [18, 19]. 
VβTCR assays have also been used in disease evaluation 
and for monitoring the progression and response of treat-
ments [17, 20, 21]. These studies have usually compared 
their results with a small sample of healthy controls [10].
We analysed 21 different VβTCR families in CD3+ T 
lymphocytes. Our estimates were similar to previously 
published estimates in children [10]. Hence, we deduce 
that atopy does not affect substantially the levels of 
VβTCR.
Older reports of flow cytometric analyses of TCR rep-
ertoire used small numbers of Vβ monoclonal antibodies 
and therefore give a less accurate picture of the diversity 
of the normal repertoire. Our study, using 21 monoclo-
nal antibodies against human class-specific V segments 
of the TCRβ chain (Vβ), covers almost 75 % of the whole 
repertoire. Further, our study is the first to detect the 
potential effects of age and sex on VβTCR repertoire 
likely to our larger sample size.
The study has some potential limitations. Given that 
no studies have thus far reported on VβTCR repertoire 
in a large sample of atopic children, it is possible that the 
effects observed due to age and sex are confounded by 
the presence of atopy. Large scale studies in non atopic 
children are required in order to address this potential 
limitation. However, given that an association between 
immunodeficiency, immune dysregulation, and atopy 
is often reported particularly in cases of antibody defi-
ciency [12]. Our estimates are nonetheless useful even 
if they apply only to comparisons within atopic popula-
tions. In addition, the comparison between our study in 
atopic children and previous studies conducted in non- 
atopic children might have been affected by differences 
in study devices and batch of the commercially available 
mono clonal antibodies. Another potential limitation of 
our study is that we were not able to exclude patients 
with asymptomatic chronic viral infections (e.g., cyto-
megalovirus (CMV), Epstein-Barr virus (EBV), herpes 
simplex virus (HSV), which might affect the VβTCR 
repertoire [22]. However, previous studies suggest that 
asymptomatic infections would not affect substantially 
the VβTCR [23]. Although previous studies suggest that 
specific food allergies may effect specific VβTCR chains 
Fig. 3 Box plots for VβTCR percentages of all CD3 cells for children 3–6 years old
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Fig. 4 Box plots for VβTCR percentages of all CD3 cells for children 7–18 years old
Table 3 VβTCR percentages for children 0–2 years
 % Mean  
(95 % CI)
All (N = 12)
% Mean  
(95 % CI)
Male (N = 5)
% Mean  
(95 % CI)
Female (N = 7)
Age years (IQR) 4.4 (3.0, 5.2) 5.0 (3.0, 5.0) 4.0 (3.5, 5.5)
Sex (% males) 41.7 % (16.5, 71.4)
Vβ_1 3.6 (2.8, 4.4) 4.1 (2.4, 5.8) 3.2 (2.2, 4.2)
Vβ_2 8.8 (7.4, 10.2) 8.2 (6.1, 10.4) 9.2 (6.8, 11.5)
Vβ_3 4.1 (2.4, 5.8) 5.6 (2.1, 9.1) 3.0 (1.1, 4.9)
Vβ_4 2.0 (1.8, 2.2) 2.0 (1.7, 2.3) 2.0 (1.6, 2.4)
Vβ_5.2 1.7 (1.4, 1.9) 1.7 (0.8, 2.6) 1.6 (1.5, 1.7)
Vβ_5.3 1.3 (0.9, 1.6) 1.4 (0.4, 2.5) 1.1 (0.9, 1.3)
Vβ_7.1 2.5 (2.3, 2.7) 2.5 (1.9, 3.0) 2.5 (2.3, 2.8)
Vβ_7.2 1.2 (0.6, 1.7) 1.7 (0.6, 2.8) 0.8 (0.3, 1.2)
Vβ_8 5.4 (4.7, 6.2) 5.3 (4.2, 6.5) 5.5 (5.0, 6.0)
Vβ_9 1.8 (1.4, 2.3) 2.1 (0.9, 3.2) 1.7 (1.1, 2.2)
Vβ_11 1.1 (1.0, 1.3) 1.2 (0.9, 1.6) 1.0 (0.8, 1.2)
Vβ_12 1.7 (1.5, 1.8) 1.8 (1.5, 2.1) 1.6 (1.3, 1,8)
Vβ_13_1 4.3 (3.9, 4.7) 4.6 (3.7, 5.6) 4.1 (3.7, 4.4)
Vβ_13_2 2.9 (2.4, 3.4) 3.3 (2.4, 4.2) 2.6 (1.8, 3.3)
Vβ_13.6 1.6 (1.4, 1.8) 1.6 (1.2, 1.9) 1.6 (1.2, 2.0)
Vβ_14 3.5 (3.2, 3.8) 3.6 (3.1, 4.0) 3.5 (2.9, 4.1)
Vβ _16 1.0 (0.8, 1.1) 1.0 (0.6, 1.4) 1.0 (0.8, 1.1)
Vβ_17 4.7 (4.5, 5.0) 4.6 (3.9, 5.3) 4.8 (4.5, 5.1)
Vβ_21.3 2.3 (2.2, 2.5) 2.4 (2.1, 2.8) 2.3 (2.0, 2.5)
Vβ_22 3.4 (3.1, 3.7) 3.1 (2.9, 3.3) 3.6 (3.1, 4.2)
Vβ_23 1.4 (0.9, 1.9) 1.9 (0.6, 3.3) 1.0 (0.8, 1.2)
Table 4 VβTCR percentages for children 3–6 years
 % Mean  
(95 % CI)
All (N = 16)
% Mean  
(95 % CI)
Male (N = 11)
% Mean  
(95 % CI)
Female (N = 5)
Age years (IQR) 1.0 (1.0, 2.0) 1.0 (0.9, 2) 1.0 (1.0, 1.0)
Sex (% males) 68.8 (41.5, 87.9)
Vβ_1 3.5 (2.9, 4.0) 3.6 (2.8, 4.4) 3.2 (2.7, 3.8)
Vβ_2 9.5 (8.9, 10.0) 9.3 (8.5, 10.1) 9.8 (8.7, 11)
Vβ_3 4.9 (3.4, 6.5) 5.2 (3.2, 7.1) 4.5 (0.3, 8.7)
Vβ_4 2.1 (0.5, 3.7) 2.1 (1.8, 2.4) 2.2 (1.8, 2.6)
Vβ_5.2 1.7 (1.5, 1.9) 2.1 (1.8, 2.3) 2.0 (1.5, 2.4)
Vβ_5.3 1.3 (1.1, 1.4) 1.3 (1.0, 1.5) 1.3 (1.1, 1.4)
Vβ_7.1 2.9 (2.6, 3.2) 2.9 (2.7, 3.2) 2.7 (1.6, 3.9)
Vβ_7.2 1.0 (0.6, 1.4) 1.1 (0.5, 1.6) 1.0 (0.3, 1.7)
Vβ_8 5.4 (5.0, 5.8) 5.1 (4.5, 5.7) 6.1 (5.4, 6.8)
Vβ_9 2.2 (1.7, 2.6) 1.9 (1.3, 2.4) 2.8 (2.0, 3.7)
Vβ_11 1.3 (1.0, 1.5) 1.2 (0.5, 1.6) 2.0 (1.5, 2.4)
Vβ_12 1.6 (1.5, 1.8) 1.6 (1.4, 1.9) 1.5 (1.2, 1.9)
Vβ_13_1 3.7 (3.3, 4.2) 4.1 (3.7, 4.5) 2.9 (2.2, 3.6)
Vβ_13_2 2.4 (1.9, 2.9) 2.6 (1.6, 2.2) 2.9 (1.8, 3.9)
Vβ_13.6 1.8 (1.6, 2.0) 1.8 (1.5, 2.0) 1.9 (1.4, 2.5)
Vβ_14 3.6 (3.2, 4.1) 3.7 (3.2, 4.3) 3.4 (2.2,4.6)
Vβ_16 1.0 (0.9, 1.0) 1.0 (0.9, 1.1) 1.0 (0.8, 1.1)
Vβ_17 5.0 (4.7, 5.3) 5.0 (4.7, 5.4) 5.0 (4.2, 5.8)
Vβ_21.3 2.5 (2.2, 2.7) 2.7 (2.1, 2.7) 2.5 (1.8, 3.2)
Vβ_22 3.8 (3.5, 4.1) 3.8 (3.4, 4.2) 3.7 (3.2, 4.2)
Vβ_23 1.4 (1.0, 1.8) 1.4 (0.8, 2.0) 1.4 (0.9, 2.0)
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we did not observe such an association likely due to the 
relatively small sample size of children with a specific 
food allergy [24].
Conclusion
In conclusion, our findings serve to establish normal refer-
ence values of VβTCR levels in atopic children and would 
contribute to detect deviations in this repertoire in atopic 
children with suspected immunodeficiency and immune-
dysregulations and malignancies Future studies assessing 
such comparisons are required to elucidate disparities that 
have clinical implications for diagnosis and management.
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